.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Novartis
Harvard Business School
Healthtrust
UBS
Citi
Teva
Moodys
Daiichi Sankyo
QuintilesIMS

Generated: December 17, 2017

DrugPatentWatch Database Preview

DOVONEX Drug Profile

« Back to Dashboard

Which patents cover Dovonex, and what generic alternatives are available?

Dovonex is a drug marketed by Leo Pharma As and Leo Pharm and is included in three NDAs.

The generic ingredient in DOVONEX is calcipotriene. There are twelve drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the calcipotriene profile page.

Summary for DOVONEX

Drug patent expirations by year for DOVONEX

Pharmacology for DOVONEX

Ingredient-typeVitamin D
Drug ClassVitamin D Analog

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leo Pharma AsDOVONEXcalcipotrieneCREAM;TOPICAL020554-001Jul 22, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneOINTMENT;TOPICAL020273-001Dec 29, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
Leo PharmDOVONEXcalcipotrieneSOLUTION;TOPICAL020611-001Mar 3, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DOVONEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Leo PharmDOVONEXcalcipotrieneSOLUTION;TOPICAL020611-001Mar 3, 1997► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneCREAM;TOPICAL020554-001Jul 22, 1996► Subscribe► Subscribe
Leo PharmDOVONEXcalcipotrieneSOLUTION;TOPICAL020611-001Mar 3, 1997► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneOINTMENT;TOPICAL020273-001Dec 29, 1993► Subscribe► Subscribe
Leo PharmDOVONEXcalcipotrieneSOLUTION;TOPICAL020611-001Mar 3, 1997► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneCREAM;TOPICAL020554-001Jul 22, 1996► Subscribe► Subscribe
Leo Pharma AsDOVONEXcalcipotrieneCREAM;TOPICAL020554-001Jul 22, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for DOVONEX

Drugname Dosage Strength RLD Submissiondate
calcipotrieneTopical Cream0.005%Dovonex`12/2/2009
calcipotrieneTopical Solution0.01%Dovonex5/19/2006

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cipla
UBS
Fuji
AstraZeneca
Chinese Patent Office
Covington
Deloitte
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot